Pharsight® Strategic Consulting Services (SCS) is a global team of scientific, clinical and technical experts dedicated to using quantitative models to improve drug development strategy and decision-making. We are:
SCS serves all major drug development geographies, with scientists and business representatives in the United States, Europe and Japan.
As the leading provider of strategic, model-based drug development consulting services, SCS has engaged on more than 100 client projects in the past year alone. Cumulatively, we have unparalleled experience across all development phases and in all major therapeutic areas.
![]()
In addition, SCS compiles therapeutically focused public-source meta-databases, from data and information in the clinical and scientific literature, to accelerate model-based assessment of your compound's performance against competing therapies.